High Throughput Screening for Expanded CTG repeats in Myotonic Dystrophy Type 1 Using Melt Curve Analysis
Russell J. ButterfieldiD, Carina E. Imburgia, Katie MayneiD, Tara M. NewcombiD, Diane Marie Dunn, Brett Duval, Marcia L. FeldkampiD, Nicholas Elwood JohnsoniD, Robert B. WeissiD
Abstract
BackgroundMyotonic dystrophy type 1 (DM1) is caused by CTG repeat expansions in the DMPK gene and is the most common form of muscular dystrophy. Patients can have long delays from onset to diagnosis, since clinical signs and symptoms are often non-specific and overlapping with other disorders. Clinical genetic testing by Southern blot or triplet-primed PCR (TP-PCR) is technically challenging and cost prohibitive for population surveys. MethodsHere, we present a high throughput, low-cost screening tool for CTG repeat expansions using TP-PCR followed by high resolution melt curve analysis with saturating concentrations of SYBR GreenER dye. ResultsWe determined that multimodal melt profiles from the TP-PCR assay are a proxy for amplicon length stoichiometry. In a screen of 10,097 newborn blood spots, melt profile analysis accurately reflected the tri-modal distribution of common alleles from 5 to 35 CTG repeats, and identified the premutation and full expansion alleles. ConclusionWe demonstrate that robust detection of expanded CTG repeats in a single tube can be achieved from samples derived from specimens with minimal template DNA such as dried blood spots (DBS). This technique is readily adaptable to large-scale testing programs such as population studies and newborn screening programs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 0.35
- Field percentile
- 45th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of a CCG-enriched expanded allele in DM1 patients using Amplification-free long-read sequencing
Yu‐Chih Tsai, Laure de Pontual, … Stéphanie Tomé·Journal of Molecular DiagnosticsPeer-reviewed·Sep 7, 2022
- A haplotype-based approach for myotonic dystrophy type 1
Claudia Moreau, Gaëlle Morin, … Simon Girard·medRxiv·Jul 13, 2026
- CCG interruptions are unstable and hypermethylated in DM1 patients
Sonia Lameiras, Eirini-Maria Lampraki, … Stéphanie Tomé·bioRxiv·Oct 10, 2024
- Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing
Massimiliano Alfano, Luca De Antoni, … Marzia Rossato·eLifePeer-reviewed·Aug 26, 2022
- Characterisation of DMPK and MBNL1 expression in cell models of Myotonic Dystrophy: A platform for drug screening
Andrea López‐Martínez, Sergio Martín‐González, … Virginia Arechavala‐Gomeza·NAR Molecular MedicinePeer-reviewed·Jun 20, 2025
- Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial
Adam Kurkiewicz, Anneli Cooper, … Darren G. Monckton·PLoS ONEPeer-reviewed·Apr 14, 2020